疫苗前沿 | 自我扩增mRNA新冠疫苗激发广泛抗体和T细胞反应，有望对多种变种提供保护

 

参考资料:

[1] Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (CORAL-BOOST) Evaluating a T Cell-Enhanced Self-Amplifying mRNA (samRNA) Vaccine Against COVID-19. Retrieved January 4, 2022, from https://ir.gritstonebio.com/news-releases/news-release-details/gritstone-announces-positive-clinical-results-first-cohort-phase

来源：药明康德

打赏